44 Wealth Management’s ResMed RMD Stock Holding History

44 Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$590K	Hold	2,700	–	–	0.2%	98
2023 Q1	$591K	Hold	2,700	–	–	0.2%	97
2022 Q4	$562K	Hold	2,700	–	–	0.19%	101
2022 Q3	$589K	Hold	2,700	–	–	0.24%	91
2022 Q2	$566K	Hold	2,700	–	–	0.22%	95
2022 Q1	$655K	Hold	2,700	–	–	0.24%	99
2021 Q4	$703K	Hold	2,700	–	–	0.24%	89
2021 Q3	$712K	Hold	2,700	–	–	0.27%	85
2021 Q2	$666K	Hold	2,700	–	–	0.26%	91
2021 Q1	$524K	Hold	2,700	–	–	0.22%	102
2020 Q4	$574K	Buy	+2,700	New	+$538K	0.26%	88

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

44 Wealth Management's RMD Position: Q2 2023 in Review

44 Wealth Management held its ResMed (RMD) position steady in Q2 2023 at 2,700 shares worth $590K. The position accounts for 0.2% of the portfolio, ranked #98.

44 Wealth Management first reported a position in RMD in Q4 2020 and has held it in 11 quarters since. The position peaked at $712K in Q3 2021. 731 funds tracked by Wall St. Rank hold RMD as of Q2 2023.

44 Wealth Management held 2,700 shares of ResMed worth $590K as of Q2 2023.
44 Wealth Management left its ResMed share count unchanged in Q2 2023.
ResMed made up 0.2% of 44 Wealth Management's portfolio in Q2 2023, its #98 holding.
44 Wealth Management first reported a position in ResMed in Q4 2020 and has held it in 11 quarters since.
44 Wealth Management's ResMed position peaked at $712K in Q3 2021.
731 funds tracked by Wall St. Rank held ResMed as of Q2 2023.

Based on 44 Wealth Management's 13F filing for Q2 2023, filed 18 Jul 2023.